2Omland T. Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in e- valuation of acute heart failure [ J 1. Crit care Med, 2008,36 ( 1 Suppl) :S17-$27.
3Dichstein k, Cohen- solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chro- nic heart failure 2008;the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the Eu- ropean society of cardiology, developed in collaboration with the heart failure association of the ESC(HFA) and endorsed by the european society of intensive care medicine (ES- ICM ) [ J ]. Eur heart, 2008,29 : 2388-2442.
4Levitt JE Vinayak AG ,Gehlbach BK, et al. Diagnostic util- ity of B-type natriuretic peptide in critically ill patients with pulmonary edema; a prospective cohort study [ J ]. Crit care, 2008,12:3.
5Rana R, Vlahakis NE, Daniels CE, et al. B-type natriuetic peptide in the assessment of acute lung injury and cardiogen- ic pulmonary edema [ J ]. Crit Care Med, 2006,34 : 194l - 1946.
6Thierry S, lecuyer L, Brocas E, etal. Interest of the brain natriuretic peptide as a marker of acute cor pulmonale in a- cute respiratory distress syndrome [ J ]. Ann Fr Anesth Re- anim,2006,25:815-819.
7Bando M, Ishii Y, Sugiyama y, et al. Elevated plasma brain natriuretic peptide levels in chronic respiratory failure with cor pulmonale[ J]. Respir Med, 1999,93:507-514.
8Nakanishi K, Tajima F, Itoh H,et al. Changes in atrial na- triuretic peptide and brain natriuretic peptide associated with hypobaric hypoxia induced pulmonary hypertension in rats [ J ]. Virchows Arch , 2001,439 .. 808-817.
9Wiedemann HP, Wheeler AP, Bernard GR, et al. Compari- son of two fluid-management strategies in acute lung injury [ J]. N Engl Med,2006 ,354 :2564-2575.
10Charpentier J, Luyt C, Fulla Y, et al. Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis [ J ]. Crit Care Med, 2004,32 : 660 - 665.
